Jun Yong Park Selected Research

acarboxyprothrombin (PIVKA)

1/2021	Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization.
1/2020	Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization.
1/2020	Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.
8/2019	Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma.
1/2019	Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection.
1/2016	Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
1/2013	Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
1/2013	Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma.
7/2012	Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.
1/2012	Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Yong Park Research Topics

Disease

109	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 09/2005
85	Chronic Hepatitis B 01/2022 - 01/2008
49	Fibrosis (Cirrhosis) 01/2022 - 04/2010
43	Neoplasms (Cancer) 05/2022 - 09/2005
39	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 02/2005
27	Infections 11/2021 - 02/2005
16	Hepatitis B 01/2022 - 04/2009
10	Non-alcoholic Fatty Liver Disease 01/2022 - 10/2015
9	Thrombosis (Thrombus) 05/2022 - 09/2005
9	Liver Neoplasms (Liver Cancer) 12/2021 - 09/2011
8	Hypertension (High Blood Pressure) 01/2022 - 11/2015
8	Neoplasm Metastasis (Metastasis) 11/2016 - 09/2008
7	Liver Diseases (Liver Disease) 10/2022 - 07/2009
7	Chronic Hepatitis C 01/2021 - 12/2009
5	Hemorrhage 01/2021 - 11/2005
5	End Stage Liver Disease 01/2021 - 09/2006
5	Disease Progression 12/2019 - 01/2008
5	Ascites 09/2019 - 04/2010
5	Hypoxia (Hypoxemia) 01/2017 - 09/2010
4	Vasculitis (Vasculitides) 01/2022 - 08/2018
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2017
4	Insulin Resistance 06/2021 - 07/2003
4	Liver Failure 01/2020 - 07/2009
4	Virus Diseases (Viral Diseases) 01/2020 - 11/2010
4	Diabetes Mellitus 06/2019 - 11/2015
3	Viremia 01/2022 - 12/2019
3	Fatty Liver 01/2022 - 12/2020
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2016
3	Hepatitis A (Hepatitis, Infectious) 01/2020 - 07/2011
3	Hepatitis 01/2019 - 07/2009
3	Inflammation (Inflammations) 01/2018 - 07/2003
2	Leukopenia 10/2021 - 07/2016
2	Obesity 06/2021 - 11/2018
2	Carcinogenesis 01/2021 - 03/2008
2	Dyslipidemias (Dyslipidemia) 12/2020 - 01/2017
2	Chronic Hepatitis (Chronic Active Hepatitis) 10/2019 - 05/2012
2	Stomach Neoplasms (Stomach Cancer) 10/2019 - 04/2010

Drug/Important Bio-Agent (IBA)

56	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2010
30	entecavir FDA Link 01/2022 - 01/2009
23	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 03/2008
22	Tenofovir (Viread)FDA Link 01/2022 - 09/2014
20	Alanine Transaminase (SGPT)IBA 01/2022 - 03/2009
19	Hepatitis B e AntigensIBA 11/2021 - 01/2008
19	Lamivudine (Epivir)FDA Link 01/2020 - 01/2008
18	Sorafenib (BAY 43-9006)FDA Link 05/2022 - 09/2011
14	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021 - 11/2009
13	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 02/2005
13	Serum AlbuminIBA 01/2022 - 03/2015
12	Pharmaceutical PreparationsIBA 12/2021 - 07/2009
11	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 04/2010
10	acarboxyprothrombin (PIVKA)IBA 01/2021 - 01/2012
10	adefovirIBA 01/2020 - 01/2009
9	BilirubinIBA 11/2021 - 07/2009
9	Fetal Proteins (Fetoprotein)IBA 01/2020 - 01/2011
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
8	lipoarabinomannan (LAM)IBA 01/2020 - 11/2010
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2010
6	AlbuminsIBA 11/2021 - 01/2019
5	AntigensIBA 01/2022 - 05/2012
5	InterferonsIBA 11/2020 - 01/2013
5	Prothrombin (Factor II)IBA 09/2019 - 01/2012
5	Tumor Biomarkers (Tumor Markers)IBA 01/2016 - 07/2012
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 08/2018
4	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2015
4	Transaminases (Aminotransferases)IBA 04/2021 - 07/2009
4	Ribavirin (Virazole)FDA LinkGeneric 11/2020 - 12/2009
4	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 01/2013
4	CytokinesIBA 01/2020 - 10/2012
4	Fluorouracil (Carac)FDA LinkGeneric 01/2013 - 07/2007
3	nasIBA 01/2022 - 06/2014
3	Aspartic Acid (Aspartate)FDA Link 01/2022 - 03/2009
3	CholesterolIBA 11/2021 - 01/2020
3	Indicators and Reagents (Reagents)IBA 10/2021 - 09/2011
3	wisteria lectinIBA 01/2020 - 01/2016
3	Carrier Proteins (Binding Protein)IBA 01/2020 - 01/2016
3	Telbivudine FDA Link 01/2020 - 01/2013
3	Vitamin K FDA Link 09/2019 - 07/2012
3	Rituximab (Mabthera)FDA Link 10/2018 - 01/2017
3	NucleosidesIBA 01/2018 - 01/2016
3	thiamine triphosphorate (TTP)IBA 01/2018 - 04/2015
3	Interleukin-8 (Interleukin 8)IBA 01/2017 - 04/2014
3	Small Interfering RNA (siRNA)IBA 04/2014 - 09/2010
3	adefovir dipivoxil (Hepsera)FDA Link 03/2013 - 01/2009
3	Cisplatin (Platino)FDA LinkGeneric 04/2011 - 07/2007
2	FumaratesIBA 01/2022 - 01/2019
2	((1- ((2- amino- 9H- purin- 9- yl)methyl)cyclopropyl)oxy)methylphosphonic acid dipivoxylIBA 12/2021 - 05/2020
2	maleic acid (maleate)IBA 12/2021 - 05/2020
2	tenofovir alafenamideIBA 11/2021 - 10/2021
2	C-PeptideIBA 06/2021 - 07/2016
2	Immunoglobulins (Immunoglobulin)IBA 12/2020 - 01/2020
2	Immune Checkpoint InhibitorsIBA 02/2020 - 10/2019
2	CreatinineIBA 01/2020 - 04/2018
2	Biological ProductsIBA 12/2019 - 10/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019 - 01/2014

Therapy/Procedure

76	Therapeutics 01/2022 - 07/2009
20	Drug Therapy (Chemotherapy) 10/2021 - 08/2002
13	Liver Transplantation 10/2022 - 09/2006
7	Chemoradiotherapy 05/2022 - 01/2011
4	Radiofrequency Ablation 09/2020 - 01/2015
4	Radiotherapy 01/2020 - 12/2010